Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Nan Fang Yi Ke Da Xue Xue Bao = Journal of Southern Medical University|August 31, 2006
[Association of psychological factors with post-partum hemorrhage and labor duration]Zhi-xiong Mei, Min Huang
Building Simulation|December 1, 2021
Predicting indoor particle dispersion under dynamic ventilation modes with high-order Markov chain modelXiong Mei, Chenni Zeng, Guangcai Gong
General Physiology and Biophysics|April 13, 2022
BDH2 promotes apoptosis and autophagy of lung adenocarcinoma cells via Akt/mTOR pathwayYongli Nie, Xiong Mei, Fengjun Cao, et al.
Archivum Immunologiae Et Therapiae Experimentalis|April 10, 2026
BDH2 Inhibits Lung Adenocarcinoma Metastasis by Promoting FerroptosisQiao Yang, Lin Tian, Xiaodong Chen, et al.
Drugs in R&D|July 21, 2023
Physicochemical and Functional Similarity Assessment Between Proposed Bevacizumab Biosimilar BAT1706 and Reference BevacizumabDi Cao, Chunping Deng, Guangying Wang, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|March 6, 2025
Comparative Structure Activity Relationship Characterization of the Biosimilar BAT1806/BIIB800 to Reference TocilizumabYujie Liu, Jianhua Xie, Zhuxiang Li, et al.
Neurotoxicity Research|August 17, 2018
Dexmedetomidine Protects Against Chemical Hypoxia-Induced Neurotoxicity in Differentiated PC12 Cells Via Inhibition of NADPH Oxidase 2-Mediated Oxidative StressXiao-Hui Chen, Dong-Tai Chen, Xiong-Mei Huang, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|June 18, 2024
Demonstration of Physicochemical and Functional Similarity of the Biosimilar BAT1806/BIIB800 to Reference TocilizumabYujie Liu, Jianhua Xie, Zhuxiang Li, et al.
Frontiers in Oncology|August 14, 2023
BAT6026, a novel anti-OX40 antibody with enhanced antibody dependent cellular cytotoxicity effect for cancer immunotherapyShizhong Liang, Dandan Zheng, Xiong Liu, et al.
Pageof 1